Comparison of salmeterol/fluticasone propionate combination with budesonide in patients with mild-to-moderate asthma

Clinical Drug Investigation

Volumn 21, Issue 9, 2001, Pages 633-642

  Johansson, G ^a   McIvor, R A ^b   D'Ambrosio, F P ^c   Gratziou, C ^d   James, M H ^e  

^a Nyby Vardcentral   (Sweden)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF MESSINA   (Italy)

^d Evenidion Hospital   (Greece)

^e GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; FLUTICASONE PROPIONATE; SALMETEROL;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GOOD CLINICAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SCORING SYSTEM; SPIROMETRY; TREATMENT OUTCOME;

EID: 0034784038     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200121090-00005     Document Type: Article

References (25)

1. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids
2. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma
3. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma
4. Inhaled fluticasone propionate and salmeterol in moderate adult asthma. I. Lung function and symptoms
5. Effect of inhaled formoterol and budesonide on exacerbations of asthma
6. Inhaled fluticasone propionate and salmeterol in moderate adult asthma. II. Exacerbations
7. Salmeterol and fluticasone propionate (50/250 μg) administered via combination Diskus inhaler: As effective as when given via separate Diskus inhalers
8. Salmeterol/fluticasone propionate (50/500μg) in combination in a Diskus inhaler (Seretide™) is effective and safe in the treatment of steroid-dependent asthma
9. Salmeterol/fluticasone combination inhaler. A new, effective and well tolerated treatment for asthma
10. Combined salmeterol 50μg and fluticasone propionate 250μg in the Diskus device for the treatment of asthma
11. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled trial
12. Clinical experience with fluticasone propionate in asthma: A meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less
13. Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases
14. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
15. The use of beta-agonists and the risk of death and near death from asthma
16. Regular inhaled beta-agonist treatment in bronchial asthma
17. Potential masking effects of salmeterol on airway inflammation in asthma
18. A twelve month comparison of salmeterol with salbutamol in asthmatic patients
19. Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA)
20. Pharmacology of long-acting beta-agonists
21. Development of fluticasone propionate and comparison with other inhaled corticosteroids
22. 2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells
23. Effects of salbutamol on bronchoconstriction, bronchial hyperresponsiveness, and leucocyte responses induced by platelet activating factor in man
24. 2-adrenergic receptor function in human nasal mucosa